Treatment-Resistant Depression in the Elderly
Apparent treatment-resistant depression (TRD) is frequently encountered by and poses particular challenges for the old-age psychiatrist. The prevalence of true nonresponse to treatment is not known with accuracy but reports put it at 18% to 40% for the elderly.
D, Bonner, R, Howard
openaire +2 more sources
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with
Courtney M. Vecera +4 more
doaj +1 more source
Metyrapone in treatment-resistant depression [PDF]
Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant depression (TRD).
Paul David, Sigalas +4 more
openaire +2 more sources
Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?
Objective: In a retrospective study, we analyzed if anxious depression impacts outcomes in patients with treatment resistant depression (TRD) receiving IV Ketamine infusions at an academic center Ketamine clinic.
Zoe Schreiber +7 more
doaj +1 more source
Nortriptyline for Treatment-Resistant Depression [PDF]
Up to 30% of patients with major depression fail to respond to an antidepressant trial, with most taking a selective serotonin reuptake inhibitor (SSRI) as initial treatment. While the tricyclic antidepressants might be effective for SSRI nonresponders, they have been relegated to third- and fourth-line treatment.
Andrew A, Nierenberg +8 more
openaire +2 more sources
TREATMENT RESISTANT DEPRESSION
Although it is reported that 25% of depressive patients remain resistant to antidepressant treatments, treatment resistant depression (TRD) has not yet been defined clearly.
Olcay YAZICI
doaj
The role of immunomodulators in treatment-resistant depression: case studies
Depression is a common mental disorder affecting more than 264 million people worldwide. The first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (SSRIs), such as sertraline, reboxetine and fluoxetine.
Charles W. Beckett +1 more
doaj +1 more source
Tavistock Adult Depression Study (TADS): a randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression [PDF]
: BACKGROUND: Long-term forms of depression represent a significant mental health problem for which there is a lack of effective evidence-based treatment.
Taylor David +24 more
core +2 more sources
Rethinking treatment-resistant depression to quasi-tenacious depression
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging.
Shokouh Arjmand +2 more
doaj +1 more source
Systematic review of clinical effectiveness of interventions for treatment resistant late-life depression. [PDF]
Treatment-resistant late-life depression (TRLLD) affects nearly half of older adults with major depression. This systematic review evaluates published evidence of effectiveness of both pharmacological and non-pharmacological treatments for TRLLD.
Gomez Bautista, D. +12 more
core +1 more source

